Nicholas Lydon
| Nicholas Lydon | |
|---|---|
| File:Nicholas Lydon.jpg | |
| Born | 27 February 1957 [citation needed] |
| Institutions | <templatestyles src="Plainlist/styles.css"/> |
| Alma mater | <templatestyles src="Plainlist/styles.css"/>
|
| Thesis | Studies on the hormone-sensitive adenylate cyclase from bovine corpus luteum (1982) |
| Known for | <templatestyles src="Plainlist/styles.css"/>
|
| Notable awards | <templatestyles src="Plainlist/styles.css"/>
|
| Website royalsociety |
|
Nicholas B. Lydon FRS (born 27 February 1957) is a British scientist and entrepreneur.[1] In 2009 he was awarded the Lasker Clinical Award and in 2012 the Japan Prize for the development of Gleevec, a selective BCR-ABL inhibitor for the treatment of chronic myeloid leukaemia (CML), which converted a fatal cancer into a manageable chronic condition.[2][3][4][5] [6][7]
Education
Dr Lydon was educated at Strathallan School near Perth, Scotland.[8] He earned a Bachelor of Science degree in biochemistry from the University of Leeds, England in 1978 and received his PhD in biochemistry from the University of Dundee, Scotland in 1982.[9][8]
Career
In 1982 Dr Lydon accepted a position with Schering-Plough based in France as Charge de Recherche.[3] Three years later he moved to Switzerland to work with Ciba-Geigy Pharmaceuticals, with whom he developed Gleevec.[8] In 1997 he established Kinetex Pharmaceuticals in Boston which was acquired by Amgen in 2000, with whom he worked until 2002.[8] Thereafter, he established several companies that continue to develop drugs to treat various conditions.[8]
Honours and awards
- Warren Alpert Foundation Prize, 2000.[3]
- Twenty First Annual AACR-Bruce F. Cain Memorial Award, 2002.[3]
- Charles F. Kettering Prize, General Motors Cancer Research Foundation, 2002.[3]
- The Lasker-DeBakey Clinical Medical Research Award, with Brian Druker and Charles Sawyers, 2009.[3]
- Doctor of Laws honoris causa, University of Dundee, 2011.[3]
- The Japan Prize, with Brian Druker and Janet Rowley, 2012.[3]
- Fellow of the Royal Society, 2013.[10]
- Royal Society GlaxoSmithKline Prize and Lecture, 2014[11]
Lydon's nomination for the Royal Society reads:
- REDIRECT Template:Cquote
- This is a redirect from a page that has been moved (renamed). This page was kept as a redirect to avoid breaking links, both internal and external, that may have been made to the old page name. For more information follow the bold category link.
References
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 3.0 3.1 3.2 3.3 3.4 3.5 3.6 3.7 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ List of publications from Microsoft Academic Search
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 8.0 8.1 8.2 8.3 8.4 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.(subscription required)
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- Pages containing links to subscription-only content
- EngvarB from September 2014
- Use dmy dates from September 2014
- Pages with broken file links
- Articles with unsourced statements from May 2013
- 1957 births
- Living people
- People educated at Strathallan School
- Alumni of the University of Leeds
- Alumni of the University of Dundee
- British biochemists
- Cancer researchers
- British company founders
- British businesspeople
- Fellows of the Royal Society
- Japan Prize laureates
